Kestra Advisory Services’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-506
Closed -$6.7K 2798
2024
Q4
$6.7K Hold
506
﹤0.01% 2629
2024
Q3
$5.05K Hold
506
﹤0.01% 2532
2024
Q2
$11.3K Hold
506
﹤0.01% 2597
2024
Q1
$29.7K Hold
506
﹤0.01% 2419
2023
Q4
$11.2K Hold
506
﹤0.01% 2257
2023
Q3
$10.9K Hold
506
﹤0.01% 2096
2023
Q2
$34.2K Hold
506
﹤0.01% 2060
2023
Q1
$236K Sell
506
-13
-3% -$6.06K ﹤0.01% 1723
2022
Q4
$208K Buy
519
+12
+2% +$4.81K ﹤0.01% 2001
2022
Q3
$165K Buy
507
+1
+0.2% +$325 ﹤0.01% 1908
2022
Q2
$134K Sell
506
-32
-6% -$8.47K ﹤0.01% 1951
2022
Q1
$162K Buy
538
+60
+13% +$18.1K ﹤0.01% 1890
2021
Q4
$168K Sell
478
-120
-20% -$42.2K ﹤0.01% 1900
2021
Q3
$153K Sell
598
-260
-30% -$66.5K ﹤0.01% 2015
2021
Q2
$571K Buy
858
+409
+91% +$272K 0.01% 1221
2021
Q1
$389K Sell
449
-15
-3% -$13K ﹤0.01% 1314
2020
Q4
$440K Buy
+464
New +$440K 0.01% 1272